Inhibitors of hepatitis C virus

Patent metadata

Field	Value
Publication number	US-9296782-B2
Application number	US-201313934090-A
Country	US
Kind code	B2
Filing date	Jul 2, 2013
Priority date	Jul 3, 2012
Publication date	Mar 29, 2016
Grant date	Mar 29, 2016

Abstract

Compounds of Formula I are disclosed

As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

First claim

What is claimed is:

1. A compound of Formula lVa:

or a pharmaceutically acceptable salt thereof.

2. A compound of claim 1 which is:

or a pharmaceutically acceptable salt thereof.

3. A compound of Formula lVc:

or a pharmaceutically acceptable salt thereof.

4. A compound of claim 3 which is:

or a pharmaceutically acceptable salt thereof.

5. A compound of Formula lVe:

or a pharmaceutically acceptable salt thereof.

6. A compound of claim 5 which is:

or a pharmaceutically acceptable salt thereof.

7. A compound of formula lVg:

or a pharmaceutically acceptable salt thereof.

8. A compound of claim 7 which is:

or a pharmaceutically acceptable salt thereof.

9. A compound which is:

10. A composition comprising the compound of claim 9 and a pharmaceutically acceptable carrier.

11. A compound which is:

12. A composition comprising the compound of claim 11 and a pharmaceutically acceptable carrier.

13. A compound which is:

14. A composition comprising the compound of claim 13 and a pharmaceutically acceptable carrier.

15. A compound which is:

16. A composition comprising the compound of claim 15 and a pharmaceutically acceptable carrier.

Assignees

• Gilead Sciences Inc

Inventors

• Bjornson Kyla
• Canales Eda
• Cottell Jeromy J
• Karki Kapil Kumar
• Katana Ashley Anne
• Kato Darryl
• Kobayashi Tetsuya
• Link John O
• Martinez Ruben
• Phillips Barton W
• Pyun Hyung-Jung
• Sangi Michael
• Schrier Adam James
• Siegel Dustin
• Taylor James G
• Tran Chinh Viet
• Trejo Martin Teresa Alejandra
• Vivian Randall W
• Yang Zheng-Yu
• Zablocki Jeff
• Zipfel Sheila

Classifications

• A61P31/14

  for RNA viruses · CPC title

• A61P31/12

  Antivirals · CPC title

• A61P31/00

  Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

• A61P31/10

  Antimycotics · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title